Microvascular perturbations in rats receiving the maximum tolerated dose of methotrexate or its major metabolite 7-hydroxymethotrexate

Ultrastructural Pathology

Volumn 24, Issue 5, 2000, Pages 325-332

  Fuskevag, O M ^a   Kristiansen, C ^a   Olsen, R ^a   Aarbakke, J ^a   Lindal, S ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

7 hydroxymethotrexate; Endothelial cells; Methotrexate; Rat; Toxicity; Ultrastructure

Indexed keywords

7 HYDROXYMETHOTREXATE; CYTOSTATIC AGENT; FOLIC ACID ANTAGONIST; METHOTREXATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DOSE CALCULATION; EDEMA; ENDOTHELIUM CELL; LIVER CELL; LIVER NECROSIS; LIVER TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; STEATOSIS; TOXICITY TESTING;

ANIMALIA;

EID: 0033773019     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.1080/019131200750035058     Document Type: Article

References (41)

1. Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck
2. Molecular mechanisms of resistance to antifolates, a review
3. Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 update)
4. Methotrexate in rheumatoid arthritis: A five-year prospective multicenter study
5. Methotrexate in rheumatoid arthritis: An update
6. Methotrexate hepatotoxicity
7. Methotrexate side-effects
8. Renal effects of low dose methotrexate in rheumatoid arthritis
9. Polyglutamation of methotrexate: Is methotrexate a prodrug?
10. Presence of 2,4-diamino-N10-methylpteroic acid after high-dose methotrexate
11. 2) in childhood malignancies: Clinical tolerability and pharmacokinetics
12. Formation and elimination of 7-hydroxymethotrexate in the rat in vivo after methotrexate administration
13. Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate
14. 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate
15. Strain differences of the ability to hydroxylate methotrexate in rats
16. Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia: Identification of a relation between concentration and effect
17. 2 to children with acute lymphoblastic leukemia
18. Kinetics of 7-hydroxy-methotrexate after high-dose methotrexate therapy
19. Dose-dependent metabolism of methotrexate in man and rhesus monkeys
20. The role of 7-hydroxymethotrexate during methotrexate anti-cancer therapy
21. 2) methotrexate therapy
22. High-dose 7-hydromethotrexate: Acute toxicity and lethality in a rat model
23. Formation of 7-hydroxymethotrexate polyglutamyl derivatives and their cytotoxicity in human chronic myelogenous leukemia cells, in vitro
24. Aldehyde oxidase mediated 7-hydroxylation of antifolates and its therapeutic relevance
25. 7-Hydroxymethotrexate cytotoxicity and selectivity in a human Burkitt's lymphoma cell line versus human granulocytic progenitor cells: Rescue by folinic acid and nucleosides
26. Maximum tolerated doses of methotrexate and 7-hydroxy-methotrexate after 8 h infusions in rats
27. Karnofsky memorial lecture: Ode to methotrexate
28. Leucovorin and maximum tolerated dose toxicity of methotrexate in rats
29. Acute hepatotoxicity after high-dose methotrexate administration to rats
30. Renal and hepatic toxicity after high-dose 7-hydroxymethotrexate in the rat
31. Weekly methotrexate-calcium leucovorin rescue: Effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma
32. Pharmacokinetics of high dose methotrexate (NSC-740)
33. Methotrexate encephalopathy: A neurological study
34. Vascular changes of methotrexate-related disseminated necrotizing leukoencephalopathy
35. Morphologic alterations in rat brain following systemic and intraventricular methotrexate injection: Light and electron microscopic studies
36. Pharmacokinetics and biochemical effects of a fatal intrathecal methotrexate overdose
37. Remission induction of meningeal leukemia with high-dose intravenous methotrexate
38. Methotrexate, II: Use in pediatric chemotherapy
39. The influence of 5-fluorouracil and methotrexate on vascular endothelium: An experimental study using endothelial cells in the culture
40. Hepatotoxicity